Search results
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 2 days agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
Coya Therapeutics’ (COYA) “Buy” Rating Reaffirmed at Chardan Capital
ETF DAILY NEWS· 15 hours agoCoya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating restated by analysts at Chardan Capital in a report released on Wednesday, Benzinga reports.
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoNovavax, Inc. NVAX shares are trading higher Wednesday, and the stock is up by more than 300% over...
Hims & Hers Health (NYSE:HIMS) Stock Price Down 1.7% on Insider Selling
ETF DAILY NEWS· 15 hours agoHims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price traded down 1.7% on Thursday following insider selling activity. The company traded as low as $21.08 and ...
Enlight Renewable Energy (NASDAQ:ENLT) Shares Gap Down to $17.73
ETF DAILY NEWS· 11 hours agoShares of Enlight Renewable Energy Ltd (NASDAQ:ENLT – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $17.73, but opened at ...
Analysts Issue Forecasts for Greif, Inc.’s Q3 2024 Earnings (NYSE:GEF)
ETF DAILY NEWS· 16 hours agoGreif, Inc. (NYSE:GEF – Free Report) – Stock analysts at Zacks Research boosted their Q3 2024 EPS...
IDACORP, Inc. (NYSE:IDA) Receives $97.40 Average Target Price from Analysts
ETF DAILY NEWS· 15 hours agoFive investment analysts have rated the stock with a hold rating. Wells Fargo & Company lifted their price target on shares of IDACORP from $94.00 to $98.00 ...
Brokerages Set Agiliti, Inc. (NYSE:AGTI) Target Price at $14.17
ETF DAILY NEWS· 15 hours agoAgiliti, Inc. (NYSE:AGTI – Get Free Report) has received a consensus recommendation of “Reduce” from the seven research firms that are currently covering the stock, Marketbeat.com ...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 14 hours agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 14 hours agoBank of America raised their price target on shares of Teva Pharmaceutical Industries from $18.00 to $21.00 and gave the stock a “buy” rating in a report ...